Claudine Tardy

1.7k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

Claudine Tardy is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Claudine Tardy has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cell Biology and 5 papers in Immunology. Recurrent topics in Claudine Tardy's work include Cell death mechanisms and regulation (4 papers), Lipid Membrane Structure and Behavior (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Claudine Tardy is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Lipid Membrane Structure and Behavior (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Claudine Tardy collaborates with scholars based in France, United States and Finland. Claudine Tardy's co-authors include Cédric Barrière, Sarah L. Hunt, Marcos Malumbres, David Santamarı́a, Pierre Dubus, Mariano Barbacid, Javier F. Cáceres, Kathryn Newton, Nathalie Andrieu‐Abadie and Thierry Levade and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Claudine Tardy

18 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cdk1 is sufficient to drive the mammalian cell cycle

2007 806 citations David Santamarı́a, Cédric Barrière et al. Nature profile →

Peers

Countries citing papers authored by Claudine Tardy

Since Specialization

Citations

This map shows the geographic impact of Claudine Tardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudine Tardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudine Tardy more than expected).

Fields of papers citing papers by Claudine Tardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudine Tardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudine Tardy. The network helps show where Claudine Tardy may publish in the future.

Co-authorship network of co-authors of Claudine Tardy

This figure shows the co-authorship network connecting the top 25 collaborators of Claudine Tardy. A scholar is included among the top collaborators of Claudine Tardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudine Tardy. Claudine Tardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling 2022 ·Frontiers in Immunology ·Laura Keller, Claudine Tardy, Lætitia Ligat, (unknown), Nicolas Béry, (unknown), Patrick Chinestra, (unknown), (unknown), Gilles Favre, Stéphanie Cabantous, Aurélien Olichon	1
2	Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer 2021 ·Analytical Chemistry ·Laura Keller, Claudine Tardy, Lætitia Ligat, Julia Gilhodes, Thomas Filleron, Nicolas Béry, Philippe Rochaix, (unknown), (unknown), Thomas Roux, Eric Trinquet, Gilles Favre, Aurélien Olichon	6
3	A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency 2020 ·Haematologica ·Chantal Lagresle‐Peyrou, Aurélien Olichon, Hanem Sadek, Philippe Roche, Claudine Tardy, (unknown), Alexandrine Garrigue, Alain Fischer, Despina Moshous, Yves Collette, Capucine Pïcard, Jean‐Laurent Casanova, Isabelle André‐Schmutz, Marina Cavazzana	11
4	An Autosomal Dominant SCID Form Due to a Gain of Function Mutation in the RAC2 Gene 2019 ·Blood ·Chantal Lagresle‐Peyrou, Aurélien Olichon, Hanem Sadek, Philippe Roche, Claudine Tardy, (unknown), Alexandrine Garrigue, Alain Fischer, Despina Moshous, Yves Collette, Capucine Pïcard, Jean‐Laurent Casanova, Isabelle André‐Schmutz, Marina Cavazzana	0
5	Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities 2019 ·Antibodies ·Laura Keller, Nicolas Béry, Claudine Tardy, Lætitia Ligat, Gilles Favre, Terence H. Rabbitts, Aurélien Olichon	23
6	HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation 2015 ·PLoS ONE ·Claudine Tardy, (unknown), Nadia Boubekeur, (unknown), Rose Ackermann, (unknown), Constance Keyserling, Narendra D. Lalwani, John F. Paolini, Jean‐Louis Dasseux, Ronald Barbaras, Rudi Baron	26
7	P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo 2014 ·PLoS ONE ·(unknown), Claudine Tardy, Nadia Boubekeur, (unknown), (unknown), Daniela C. Oniciu, Narendra D. Lalwani, (unknown), Ronald Barbaras, Rudi Baron	18
8	CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice 2013 ·Atherosclerosis ·Claudine Tardy, (unknown), Nadia Boubekeur, Rose Ackermann, (unknown), (unknown), (unknown), Constance Keyserling, Narendra D. Lalwani, John F. Paolini, Jean‐Louis Dasseux, Ronald Barbaras, Rudi Baron	92
9	Abstract 18667: Anti-atherosclerotic Effect of CER-001, an Engineered HDL-mimetic, in the High-fat Diet-fed LDLr Knockout Mice 2012 ·Circulation ·(unknown), Claudine Tardy, (unknown), Nadia Boubekeur, Rudi Baron, Constance Keyserling, Ronald Barbaras, Narendra D. Lalwani, Jean‐Louis Dasseux	4
10	Palmitoyl protein thioesterase 1 modulates tumor necrosis factor α-induced apoptosis 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Claudine Tardy, Frédérique Sabourdy, Virginie Garcia, Anu Jalanko, (unknown), Thierry Levade, Nathalie Andrieu‐Abadie	30
11	Cdk1 is sufficient to drive the mammalian cell cycle breakdown → 2007 ·Nature ·David Santamarı́a, Cédric Barrière, (unknown), Sarah L. Hunt, Claudine Tardy, Kathryn Newton, Javier F. Cáceres, Pierre Dubus, Marcos Malumbres, Mariano Barbacid	806
12	Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle) 2005 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Claudine Tardy, Patrice Codogno, Hélène Autefage, Thierry Levade, Nathalie Andrieu‐Abadie	90
13	Lysosomal Storage Diseases: Is Impaired Apoptosis a Pathogenic Mechanism? 2004 ·Neurochemical Research ·Claudine Tardy, Nathalie Andrieu‐Abadie, Robert Salvayre, Thierry Levade	19
14	Mannose 6-Phosphorylated Proteins Are Required for Tumor Necrosis Factor-induced Apoptosis 2004 ·Journal of Biological Chemistry ·Claudine Tardy, Hélène Autefage, Virginie Garcia, Thierry Levade, Nathalie Andrieu‐Abadie	18
15	Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D 2003 ·Cell Death and Differentiation ·Claudine Tardy, Jaana Tyynelä, Andrej Hasilík, Thierry Levade, Nathalie Andrieu‐Abadie	29
16	Voies de signalisation de l’apoptose médiées par les sphingolipides 2003 ·Journal de la Société de Biologie ·Olivier Cuvillier, Nathalie Andrieu‐Abadie, Bruno Ségui, Sophie Malagarie‐Cazenave, Claudine Tardy, Elisabeth Bonhoure, Thierry Levade	6
17	[Sphingolipid-mediated apoptotic signaling pathways]. 2003 ·PubMed ·Olivier Cuvillier, Nathalie Andrieu‐Abadie, Bruno Ségui, Sophie Malagarie‐Cazenave, Claudine Tardy, Elisabeth Bonhoure, Thierry Levade	6
18	Sphingolipid signalling: molecular basis and role in TNF-α-induced cell death 2002 ·Expert Reviews in Molecular Medicine ·Sophie Malagarie‐Cazenave, Nathalie Andrieu‐Abadie, Bruno Ségui, Valérie Gouazé‐Andersson, Claudine Tardy, Olivier Cuvillier, Thierry Levade	19
19	Ceramide in Apoptosis: A Revisited Role 2002 ·Neurochemical Research ·Thierry Levade, Sophie Malagarie‐Cazenave, Valérie Gouazé‐Andersson, Bruno Ségui, Claudine Tardy, (unknown), Nathalie Andrieu‐Abadie, Olivier Cuvillier	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact